Jim Cramer Was Right About These 5 Stocks

3. Merck & Co Inc (NYSE:MRK)

Number of Hedge Fund Investors: 98

Cramer’s Recommendation: Buy

YTD Performance in 2024: +13%

Jim Cramer praised Merck & Co Inc (NYSE:MRK) shares in October 2023 when he was asked about his thoughts on the healthcare company. Back in the summer of 2023 Cramer had said that Merck & Co Inc (NYSE:MRK) was doing a “terrific job” at reinventing itself. Merck & Co Inc (NYSE:MRK) shares have gained about 14% in 2024 through February 26.

As of the end of the fourth quarter of 2023, 98 hedge funds tracked by Insider Monkey had stakes in Merck & Co Inc (NYSE:MRK).

Carillon Eagle Mid Cap Growth Fund made the following comment about Merck & Co., Inc. (NYSE:MRK) in its Q3 2023 investor letter:

“Merck & Co., Inc. (NYSE:MRK) underperformed in the third quarter, based on what we view as largely macroeconomic-related factors. The company continues to execute well, both clinically and fundamentally, but much of the biopharmaceutical industry has been weak as investors are gravitating to other, more cyclical sectors.”

1281292 - 11759070 - 1